Observational Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Sep 14, 2019; 25(34): 5197-5209
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5197
Table 2 Pathological features
Histology, n (%)Patients (n = 72)
NEC61 (84.7)
NET G311 (15.3)
General classification of tumor, n (%)
Ulcerative type29 (40.3)
Protruding type29 (40.3)
Unrecorded14 (19.4)
Synaptophysin, n (%)
Positive63 (87.5)
Negative4 (5.6)
Unrecorded5 (6.9)
Chromogranin, n (%)
Positive38 (52.8)
Negative28 (38.9)
Unrecorded6 (8.3)
Neuron specific enolase, n (%)
Positive9 (12.5)
Negative5 (6.9)
Unrecorded58 (80.6)
CD56, n (%)
Positive42 (58.3)
Negative9 (12.5)
Unrecorded21 (29.2)
CDX-2, n (%)
Positive18 (25)
Negative11 (15.3)
Unrecorded43 (59.7)
TTF-1, n (%)
Positive2 (2.8)
Negative11 (15.3)
Unrecorded59 (81.9)
Ki 67 (median, range)70% (25%-95%)
EMVI, n (%)
Yes29 (40.3)
No9 (12.5)
Unrecorded34 (47.2)
Perineural invasion, n (%)
Yes8 (11.1)
No29 (40.3)
Unrecorded35 (48.6)